In this issue:
FMT offers promise in UC
Examining the risk of thiopurineinduced leukopenia
Is vedolizumab linked to postoperative infectious complications?
Predicting acute severe colitis within 3 years of diagnosis
Recurrence of Crohn’s disease after TC-PI
Infliximab or adalimumab for Crohn’s disease?
Tofacitinib improves disease activity in CD
Minimising placebo response in the CD study design
Do thiopurines reduce the risk of surgery in elderly-onset IBD?
Please login below to download this issue (PDF)